Senti Biosciences Holdings (SNTI) Long-Term Debt Issuances (2021)
Senti Biosciences Holdings (SNTI) posted Long-Term Debt Issuances of $250000.0 for Q4 2021, little changed on a QoQ basis from $250000.0 in Q3 2021.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Long-Term Debt Issuances (2021) Analysis & Trends
Senti Biosciences Holdings has reported Long-Term Debt Issuances for 1 years, with the latest figure at $250000.0 in Q4 2021.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $250000.0 in Q4 2021; TTM through Sep 2023 was $250000.0, a 66.67% decrease from a year earlier, with the FY2022 full-year figure at $5.2 million, changed N/A from the prior year.
- Long-Term Debt Issuances was $250000.0 for Q4 2021 at Senti Biosciences Holdings, roughly flat from $250000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $250000.0 in Q2 2021, with the low at $250000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.43 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.61 Bn | 2.65 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.24 Bn | 1.44 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | - |
| 10 | Senti Biosciences Holdings | 9.34 Mn | 9.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 250,000.00 |
| Sep 30, 2021 | 250,000.00 |
| Jun 30, 2021 | 250,000.00 |